If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Regulatory News (AGL)

  • There is currently no data for AGL

Geomerics secures joint development agreement

15 Mar 2010 09:59

RNS Number : 5676I
Angle PLC
15 March 2010
 



 

 

For immediate release

15 March 2010

 

ANGLE plc ("the Company")

Geomerics secures joint development agreement with CCP and Epic Games

 

ANGLE plc ("ANGLE"), the international venture management company focusing on the commercialisation of technology and the development of technology-based industry, is delighted to announce that its 47% portfolio company Geomerics has entered into a joint development agreement with CCP, creator of Eve Online, to integrate Geomerics' Enlighten real-time radiosity lighting product with Epic Games' Unreal Engine 3 for use in the development of DUST 514™.

 

DUST 514™ is the genre-defining, console MMO First-Person Shooter set within the same universe as EVE Online, the award-winning science-fiction MMO for the PC platform.

 

Currently in development at CCP's Shanghai studio, DUST 514 is the first scheduled console game to combine the use of Enlighten with Unreal Engine 3 to produce fully dynamic lighting for console platforms.

 

Thanks to their joint work with CCP, Geomerics' cutting-edge middleware lighting technology is now fully integrated with DUST 514. The only genuine real time radiosity product for gaming, Enlighten enables artists to enhance mood and atmosphere through lighting design at minimal cost.

 

"Having already produced stunning real-time radiosity results with Geomerics' Enlighten technology on the PC platform, we entered into a partnership with them to integrate their technology with Unreal Engine 3. The results knocked my socks off," said Hilmar Petursson, CEO of CCP. "Additionally, we now have rapid iteration on the lighting which is crucial to achieve the high bar we have set for Dust 514."

 

"Our advanced lighting technology will help players immerse themselves in the incredible universe CCP is creating," said Gary Lewis, CEO Geomerics. "We look forward to seeing how CCP will take advantage of the integration between Unreal Engine 3 and Enlighten in this new category of videogame."

 

 

For further information:

 

ANGLE plc

01483 685830

Andrew Newland, Chief Executive

Ian Griffiths, Finance Director

 

Collins Stewart Europe Limited

Stewart Wallace

 

0207 523 8350

Scott Harris

Stephen Scott, James O'Shaughnessy, Harry Dee

 

0207 653 0030

 

 

Notes to Editors

 

ANGLE plc 

 

Founded in 1994, ANGLE is an international venture management company focusing on the commercialisation of technology and the development of technology-based industry. ANGLE creates, develops and advises technology businesses on its own behalf and for its clients.

 

ANGLE's specialist Management services business provides support on a fee-for-service basis to major clients around the world involved in incubation, IP commercialisation, SME innovation and growth and the operation of science & technology parks.

 

ANGLE also owns a portfolio of companies with high growth potential in the medical and technology sectors in both the UK and the US. These have been developed whilst subsidiaries of ANGLE using its proprietary Progeny® process. ANGLE seeks to retain a substantial shareholding in these companies with a view to ongoing returns from dividend, milestone, royalty and capital returns.

 

ANGLE's venture management and technology commercialisation skills are of increasing relevance as global economies focus on regeneration, innovation and value added components to their industries. ANGLE's technology skills in IT and software, medical and life sciences, clean tech and renewable energies are directly relevant to major growth markets of the future and are marketed as specialised Management services.

 

ANGLE is quoted on AIM (AGL.L); further information can be found on www.ANGLEplc.com 

 

CCP

 

CCP is a privately held company that specializes in the creation, development and distribution of massively multiplayer online games (MMOG). Founded in 1997, CCP is recognized internationally as a pioneer in the single-server persistent universe concept of the MMOG genre. CCP is headquartered in Reykjavík, Iceland.

 

Unreal Engine 3

 

The award-winning Unreal Engine is known for cutting-edge graphics and its best-of-breed toolset. Unreal Engine 3 maintains those features in addition to multi-core processor support, Xbox 360® and PLAYSTATION®3 optimizations, massive world support, and a highly mature tool pipeline. Unreal Engine 3's consistently evolving toolset is designed to accelerate developers' productivity for PC and console games, visualization applications, training simulations, and linear animated content. Additional information on Unreal Engine can be obtained through the Unreal Technology Web site at www.unrealtechnology.com.

 

Epic Games

 

Epic Games, Inc., based in Cary, NC and established in 1991, develops cutting-edge games and cross-platform game engine technology. The company has created multiple million-selling, award-winning titles in its "Unreal" series, including "Unreal Tournament 3" for PC, PLAYSTATION®3 and Xbox 360®. Epic's "Gears of War" won over 30 Game of the Year awards, and the sales of "Gears of War" and "Gears of War 2" have eclipsed 11 million units. Epic's Unreal Engine 3 is the three-time consecutive winner of Game Developer magazine's Best Engine Front Line Award, was the 2008 Hall of Fame inductee and won Best Engine again in 2009. Unreal Engine 3 has also been recognized as the number one game engine by Develop magazine. Additional information about Epic can be obtained through the Epic Games Web site at www.epicgames.com.

 

Epic, Epic Games, Gears of War, Gears of War 2, Unreal, Unreal Engine and Unreal Tournament are trademarks or registered trademarks of Epic Games, Inc. in the United States of America and elsewhere. All other trademarks are the property of their respective owners.

 

Geomerics

 

Geomerics is an innovation-led company specialising in graphics software for the games industry. It is built on a combination of advanced in-house IP, a world-class research team, and strong management experience. The company's first product is Enlighten. Enlighten radically transforms the way that lighting is handled in computer games. Instead of pre-baking the effects of global illumination into the scene they can now be computed at run time, allowing for fully dynamic lighting. This dramatically enhances realism as well as opening up a new world of creative possibilities for designers and artists. Further information can be found on www.geomerics.com, or see us on the Intel and nVidia booths at GDC 2010.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLIFEAVDIELII
Date   Source Headline
5th Dec 20237:00 amRNSANGLE launches Portrait+ CTC kit at SABCS
9th Nov 20237:00 amRNSLaunch of PD-L1 test to support cancer studies
9th Nov 20237:00 amRNSTrading and business update
25th Oct 20237:00 amRNSSupporting characterisation of CTCs in HNSCC
3rd Oct 20237:00 amRNSParsortix outperforms standard for DTC harvest
29th Sep 20237:00 amRNSParsortix system showcased at ACTC conference
7th Sep 20237:00 amRNSInterim Results for the period ended 30 June 2023
4th Sep 20237:00 amRNSANGLE launch of Portrait Flex assay
15th Aug 20237:00 amRNSANGLE notice of interim results
28th Jun 20234:54 pmRNSResult of 2023 Annual General Meeting
27th Jun 202312:24 pmRNSStandard form for notification of major holdings
5th Jun 20237:00 amRNSANGLE announces senior management appointments
25th May 20237:00 amRNSPharma services contract with Artios Pharma
22nd May 20237:00 amRNSBoard change - appointment of new Chairman
21st Apr 202312:04 pmRNSANGLE presentation via Investor Meet Company
21st Apr 20237:00 amRNSResults for the year ended 31 December 2022
19th Apr 20237:00 amRNSANGLE announces partnership with BioView
17th Apr 20237:00 amRNSANGLE Parsortix poster presented at AACR 2023
13th Apr 20237:00 amRNSPharma Services Contract with Crescendo Biologics
3rd Apr 20237:00 amRNSNotice of Preliminary Results and Webcast
10th Mar 20237:00 amRNSIssue of LTIP Options and Share Options
9th Mar 20233:03 pmRNSHolding(s) in Company
9th Feb 20232:44 pmRNSDirector/PDMR shareholding
19th Jan 20237:00 amRNSAppointment of Non-Executive Director
11th Jan 20235:20 pmRNSHolding(s) in Company
10th Jan 20236:20 pmRNSHolding(s) in Company
6th Jan 202311:05 amRNSSecond Price Monitoring Extn
6th Jan 202311:00 amRNSPrice Monitoring Extension
5th Jan 20239:05 amRNSSecond Price Monitoring Extn
5th Jan 20239:00 amRNSPrice Monitoring Extension
5th Jan 20237:01 amRNSAppointment of Non-Executive Director
5th Jan 20237:00 amRNSBusiness Update
12th Dec 20227:00 amRNSTwo Parsortix posters presented at SABCS
2nd Dec 20225:30 pmRNSIssue of Equity
2nd Nov 20227:00 amRNSMultiple downstream analysis techniques for CTCs
1st Nov 20224:41 pmRNSSecond Price Monitoring Extn
1st Nov 20224:35 pmRNSPrice Monitoring Extension
24th Oct 20227:00 amRNSParsortix poster presented at ISLB meeting
21st Oct 20226:15 pmRNSIssue of Equity
18th Oct 20227:00 amRNSStreamlining of operations to increase cash runway
17th Oct 20222:23 pmRNSTR-1: Notification of major holdings
12th Oct 20227:00 amRNSFirst regional distribution agreement
30th Sep 20225:30 pmRNSHolding(s) in Company
30th Sep 20225:30 pmRNSIssue of Equity
29th Sep 20227:00 amRNSInterim Results
29th Sep 20227:00 amRNSPositive headline results from ovarian study
28th Sep 20227:00 amRNSStudy using Parsortix in head and neck cancer
13th Sep 20227:00 amRNSNew poster presented at ASCP Meeting
12th Sep 20227:30 amRNSNovel assay predicts malignancy in pelvic mass
1st Sep 20227:00 amRNSNotice of Interim Results and Webcast

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.